Position history for Carlyle Group Inc.'s holdings in Spyre Therapeutics, Inc.
Carlyle Group Inc. holds 9,620 shares of SYRE (Spyre Therapeutics, Inc.), worth $315,055 as of 2025-Q4. This is a new position. SYRE represents 0.0% of Carlyle Group Inc.'s portfolio.
Current Value
$315,055
Current Shares
9,620
Total Value Change
-$49,735
Total Shares Change
0
Other major holders of SYRE: FMR LLC, BlackRock, Inc.
New |
| 9,620 |
- |
| $315,055 |
| 0.0% |
| $31.88 |
36 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $17.94 | 0 |
| 2024-Q4 | Unchanged | 9,620 | 0.0% | $223,761 | 0.0% | $22.54 | 0 |
| 2024-Q3 | Unchanged | 9,620 | 0.0% | $282,443 | 0.0% | $28.49 | 0 |
| 2024-Q2 | Unchanged | 9,620 | 0.0% | $226,936 | 0.0% | $23.51 | 0 |
| 2024-Q1 | Unchanged | 9,620 | 0.0% | $364,790 | 0.0% | $37.93 | 0 |